PT94464A - Processo para a preparacao de uma composicao farmaceutica apropriada para a utilizacao combinada em terapia de derivados n-imidazolilicos de compostos biciclicos e de ciclosporina - Google Patents

Processo para a preparacao de uma composicao farmaceutica apropriada para a utilizacao combinada em terapia de derivados n-imidazolilicos de compostos biciclicos e de ciclosporina Download PDF

Info

Publication number
PT94464A
PT94464A PT94464A PT9446490A PT94464A PT 94464 A PT94464 A PT 94464A PT 94464 A PT94464 A PT 94464A PT 9446490 A PT9446490 A PT 9446490A PT 94464 A PT94464 A PT 94464A
Authority
PT
Portugal
Prior art keywords
imidazolyl
pharmaceutical composition
dihydro
cyclosporin
formula
Prior art date
Application number
PT94464A
Other languages
English (en)
Portuguese (pt)
Inventor
Paolo Cozzi
Corrado Ferti
Patricia Salvati
Paola Alessandrini
Original Assignee
Erba Farmitalia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Farmitalia filed Critical Erba Farmitalia
Publication of PT94464A publication Critical patent/PT94464A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Transplantation (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
PT94464A 1989-06-23 1990-06-22 Processo para a preparacao de uma composicao farmaceutica apropriada para a utilizacao combinada em terapia de derivados n-imidazolilicos de compostos biciclicos e de ciclosporina PT94464A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898914525A GB8914525D0 (en) 1989-06-23 1989-06-23 Combined use of n-imidazolyl derivatives of bicyclic compounds and cyclosporine in therapy

Publications (1)

Publication Number Publication Date
PT94464A true PT94464A (pt) 1991-02-08

Family

ID=10658992

Family Applications (1)

Application Number Title Priority Date Filing Date
PT94464A PT94464A (pt) 1989-06-23 1990-06-22 Processo para a preparacao de uma composicao farmaceutica apropriada para a utilizacao combinada em terapia de derivados n-imidazolilicos de compostos biciclicos e de ciclosporina

Country Status (13)

Country Link
EP (1) EP0433427A1 (ja)
JP (1) JPH04500375A (ja)
KR (1) KR920700669A (ja)
AU (1) AU636898B2 (ja)
CA (1) CA2035032A1 (ja)
GB (1) GB8914525D0 (ja)
HU (1) HUT55989A (ja)
IE (1) IE902266A1 (ja)
IL (1) IL94765A0 (ja)
MY (1) MY105822A (ja)
PT (1) PT94464A (ja)
WO (1) WO1991000102A1 (ja)
ZA (1) ZA904882B (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL91542A0 (en) * 1988-10-06 1990-04-29 Erba Carlo Spa N-imidazolyl-and n-imidazolyl-methyl derivatives of substituted bicyclic compounds,their preparation and pharmaceutical compositions containing them

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2141705B (en) * 1983-06-20 1986-09-24 Erba Farmitalia Imidazoles
EP0300675A3 (en) * 1987-07-21 1990-04-11 Merck Frosst Canada Inc. Method for the improvement of cyclosporine therapy

Also Published As

Publication number Publication date
HUT55989A (en) 1991-07-29
AU636898B2 (en) 1993-05-13
GB8914525D0 (en) 1989-08-09
IL94765A0 (en) 1991-04-15
MY105822A (en) 1995-01-30
AU5958490A (en) 1991-01-17
ZA904882B (en) 1992-02-26
EP0433427A1 (en) 1991-06-26
WO1991000102A1 (en) 1991-01-10
CA2035032A1 (en) 1990-12-24
IE902266A1 (en) 1991-01-16
JPH04500375A (ja) 1992-01-23
HU905625D0 (en) 1991-06-28
KR920700669A (ko) 1992-08-10

Similar Documents

Publication Publication Date Title
US20190298698A1 (en) Therapeutic approaches for treating alzheimer disease and related disorders through a modulation of synapse function
RU2048812C1 (ru) Способ лечения воспалительных заболеваний глаза и средство для лечения воспалительных заболеваний глаза
WO2003007933A1 (en) Napthoquinone derivatives as inhibitors of tau aggregation for the treatment of alzheimer's and related neurodegenerative disorders
KR101996245B1 (ko) 선택적 s1p1 수용체 아고니스트를 포함하는 약학 조합물
JP2002537258A (ja) 高血圧の治療のための医薬
US9402818B2 (en) Use of amides of mono- and dicarboxylic acids in the treatment of renal diseases
JP2009539996A (ja) 腎機能障害を持つ個体における利尿改善方法
CA3021356C (en) Compositions and methods of treating muscular dystrophy with thromboxane-a2 receptor antagonists
TW200817401A (en) KW-3902 conjugates that do not cross the blood-brain barrier
CN114555577A (zh) 用于治疗门静脉炎症和纤维化的噻吩衍生物
JPS58203911A (ja) プロスタグランジン類似化合物を有効成分として含有する細肪障害治療剤
Davies et al. The pro‐drug sulindac may reduce the risk of intestinal damage associated with the use of conventional non‐steroidal anti‐inflammatory drugs
PT94464A (pt) Processo para a preparacao de uma composicao farmaceutica apropriada para a utilizacao combinada em terapia de derivados n-imidazolilicos de compostos biciclicos e de ciclosporina
US5504084A (en) Pharmaceutical for the treatment of skin disorders
EP0081006A1 (en) Pharmaceutical compositions comprising 7,8-dihydroxy-1(hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine derivatives and a beta-adrenergic blocking compound
JP3363440B2 (ja) 脊髄小脳変性症治療剤および脊髄小脳変性症治療用組成物
US6350768B1 (en) Combination of riluzole and of gabapentin and its use as a medicament
US20120010264A1 (en) Novel medicament for treating cognitive impairment
JPH01131113A (ja) 脳障害治療剤
US5192806A (en) Method of preventing penile tissue degenerative change
WO2016205539A1 (en) Non-hormonal male contraceptive agents and methods using same
JPWO2004096230A1 (ja) 関節リウマチ治療剤
US3034961A (en) alpha-phenyl-orthomethoxy cinnamic acid choleretic process and pharmaceutical dosagecomposition
US5010096A (en) Method of protecting mammals against neuronal damage resulting from cerebral ischemia
JPS6092216A (ja) 抗リウマチ剤

Legal Events

Date Code Title Description
FC3A Refusal

Effective date: 19960506